Stuart Parmenter - 1Life Healthcare Chief Officer
ONEMDelisted Stock | USD 16.47 0.00 0.00% |
Insider
Stuart Parmenter is Chief Officer of 1Life Healthcare
Phone | 415 814 0927 |
Web | https://www.onemedical.com |
1Life Healthcare Management Efficiency
The company has return on total asset (ROA) of (0.0882) % which means that it has lost $0.0882 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2345) %, meaning that it created substantial loss on money invested by shareholders. 1Life Healthcare's management efficiency ratios could be used to measure how well 1Life Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.1Life Healthcare currently holds 309.84 M in liabilities with Debt to Equity (D/E) ratio of 0.39, which is about average as compared to similar companies. 1Life Healthcare has a current ratio of 2.54, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about 1Life Healthcare's use of debt, we should always consider it together with its cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
CMA CPA | Catalyst Pharmaceuticals | 51 | |
Tamla OatesForney | Summit Materials | 48 | |
Cameron PEng | Western Copper and | N/A | |
J Smith | GMS Inc | 71 | |
Tamla Forney | Summit Materials | 49 | |
Travis Hendren | GMS Inc | 49 | |
Gary MD | Catalyst Pharmaceuticals | 68 | |
Elena Spivak | Western Copper and | N/A | |
Philip Schwartz | Catalyst Pharmaceuticals | 69 | |
Manuel Pea | Cementos Pacasmayo SAA | 58 | |
Daniel Castillo | Jeld Wen Holding | 52 | |
Diego Silva | Cementos Pacasmayo SAA | 43 | |
Christopher Teachout | Jeld Wen Holding | N/A | |
Brian JD | Tscan Therapeutics | 55 | |
Christopher Gaskill | Summit Materials | 42 | |
Shawn Laskoski | Jeld Wen Holding | N/A | |
Tomasz Kula | Tscan Therapeutics | N/A | |
Eric Sundby | GMS Inc | N/A | |
Venkat Krishnamurthy | Cementos Pacasmayo SAA | 49 | |
Brian JD | Catalyst Pharmaceuticals | 60 | |
Ray Lockard | Tscan Therapeutics | N/A |
Management Performance
Return On Equity | -0.23 | |||
Return On Asset | -0.0882 |
1Life Healthcare Leadership Team
Elected by the shareholders, the 1Life Healthcare's board of directors comprises two types of representatives: 1Life Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 1Life. The board's role is to monitor 1Life Healthcare's management team and ensure that shareholders' interests are well served. 1Life Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, 1Life Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ken Goff, VP Relations | ||
Lisa Mango, Gen Sec | ||
Vikas Agarwal, Chief Officer | ||
Christine Morehead, Chief Officer | ||
Amir MBA, CEO Chairman | ||
Stuart Parmenter, Chief Officer | ||
Christopher Hollander, Chief Officer | ||
Trent Green, Chief Officer | ||
Bjorn Thaler, CFO Officer |
1Life Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is 1Life Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.23 | |||
Return On Asset | -0.0882 | |||
Profit Margin | (0.39) % | |||
Operating Margin | (0.37) % | |||
Current Valuation | 3.85 B | |||
Shares Outstanding | 204.35 M | |||
Shares Owned By Insiders | 1.97 % | |||
Shares Owned By Institutions | 87.10 % | |||
Number Of Shares Shorted | 15.16 M | |||
Price To Book | 2.23 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in 1Life Stock
If you are still planning to invest in 1Life Healthcare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the 1Life Healthcare's history and understand the potential risks before investing.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Transaction History View history of all your transactions and understand their impact on performance | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
CEOs Directory Screen CEOs from public companies around the world |